PLEGRIDY (peginterferon beta-1a) receives SMC approval for the treatment of relapsing remitting multiple sclerosis
Today Topics ,
PLEGRIDY® (peginterferon beta-1a) has been approved by the Scottish Medicines Consortium (SMC) as a treatment for adults with…